Journal ArticleOPEN ACCESS

Long-Term Survival and Gradual Recovery of B Cells in Patients With Refractory Large B-Cell Lymphoma Treated With Axicabtagene Ciloleucel

Clinical Advances in Hematology and Oncology (2022) 19(3) 4-5
DOI: 10.1182/blood-2020-134362
1Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Long-Term Survival and Gradual Recovery of B Cells in Patients With Refractory Large B-Cell Lymphoma Treated With Axicabtagene Ciloleucel. (2022). Clinical Advances in Hematology and Oncology, 19(3), 4–5. https://doi.org/10.1182/blood-2020-134362

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free